Recognition, Staging, and Management of Melanoma

被引：2
作者：
Rashid, Sarem [1 ,2 ]
Tsao, Hensin [1 ]
机构：
[1] Massachusetts Gen Hosp, Wellman Ctr Photomed, Dept Dermatol, Boston, MA 02466 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
来源：
MEDICAL CLINICS OF NORTH AMERICA | 2021年 / 105卷 / 04期
关键词：
Melanoma; Staging; Management; Treatment; Heterogeneity; MOHS MICROGRAPHIC SURGERY; UGLY-DUCKLING SIGN; METASTATIC MELANOMA; MEK INHIBITORS; PHASE-III; MICROSCOPIC SATELLITES; MALIGNANT-MELANOMA; TARGETED THERAPY; UNITED-STATES; HIGH-RISK;
D O I：
10.1016/j.mcna.2021.04.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：643 / 661
页数：19
相关论文
共 101 条
[71]   Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma [J].
Middleton, MR ;
Grob, JJ ;
Aaronson, N ;
Fierlbeck, G ;
Tilgen, W ;
Seiter, S ;
Gore, M ;
Aamdal, S ;
Cebon, J ;
Coates, A ;
Dreno, B ;
Henz, M ;
Schadendorf, D ;
Kapp, A ;
Weiss, J ;
Fraass, U ;
Statkevich, P ;
Muller, M ;
Thatcher, N .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :158-166
[72]  
MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
[73]  
Morton DL, CLIN CHARACTERISTICS
[74]   The future of cancer immunotherapy: microenvironment-targeting combinations [J].
Murciano-Goroff, Yonina R. ;
Warner, Allison Betof ;
Wolchok, Jedd D. .
CELL RESEARCH, 2020, 30 (06) :507-519
[75]   MC1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer [J].
Nasti, Tahseen H. ;
Timares, Laura .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2015, 91 (01) :188-200
[76]   Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study [J].
O'Day, S. J. ;
Maio, M. ;
Chiarion-Sileni, V. ;
Gajewski, T. F. ;
Pehamberger, H. ;
Bondarenko, I. N. ;
Queirolo, P. ;
Lundgren, L. ;
Mikhailov, S. ;
Roman, L. ;
Verschraegen, C. ;
Humphrey, R. ;
Ibrahim, R. ;
de Pril, V. ;
Hoos, A. ;
Wolchok, J. D. .
ANNALS OF ONCOLOGY, 2010, 21 (08) :1712-1717
[77]   The blockade of immune checkpoints in cancer immunotherapy [J].
Pardoll, Drew M. .
NATURE REVIEWS CANCER, 2012, 12 (04) :252-264
[78]   Current Advances in the Treatment of BRAF-Mutant Melanoma [J].
Patel, Hima ;
Yacoub, Nour ;
Mishra, Rosalin ;
White, Aaron ;
Yuan, Long ;
Alanazi, Samar ;
Garrett, Joan T. .
CANCERS, 2020, 12 (02)
[79]   Update in genetic susceptibility in melanoma [J].
Potrony, Miriam ;
Badenas, Celia ;
Aguilera, Paula ;
Anton Puig-Butille, Joan ;
Carrera, Cristina ;
Malvehy, Josep ;
Puig, Susana .
ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (15)
[80]   Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: Pathologic corollary of eastern cooperative oncology group trial E1690 [J].
Rao, UNM ;
Ibrahim, J ;
Flaherty, LE ;
Richards, J ;
Kirkwood, JM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2053-2057
234567891011